. . .

We’re excited to announce that in recognition of our continued dedication to exceptional quality pharma services, we have just passed our latest GMP inspection by the Czech State Institute for Drug Control, SUKL.

Inspecting QUINTA-ANALYTICA’s facilities in our HQ in Prague and also at our newest lab in the southern Czech city of Brno, the pass in both locations this week once again confirms our position as a fully certified service provider to the global pharmaceutical industry. Something we’ve been doing for over twenty years.

Providing services that span the whole pharmaceutical spectrum and combining them with unrivaled expertise across analytical services, clinical studies, R&D and more, passing both inspections eulogizes another year of growth and success for Quinta and, most importantly, our partners and clients!

Additional News

  • 17 December 2025

    PF 2026: Thank You from Quinta-Analytica

    In 2025, Quinta-Analytica continued to turn complex development challenges into tangible progress. Our PF 2026 message looks back at key milestones and thanks the partners, clients, and teams who made them possible.

  • 15 December 2025

    IVBE for locally acting drugs: insights from Conscio Science Day in Munich

    Can bioequivalence for locally acting drugs be demonstrated without a single subject in a clinical trial? Yes, if your in vitro bioequivalence (IVBE) toolkit is set up in the right way.

  • 20 November 2025

    Webinar: Streamlined Evidence Strategies for Biosimilars: Analytics, PK and Immunogenicity in focus

    On behalf of Conscio Group, we are pleased to invite you to the upcoming free educational webinar from biosimilar series.